Global Contraceptives Drugs and Devices Market Research Report 2024, Forecast to 2032
Report Overview
Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There are five widely used contraceptive methods namely barrier method, hormonal method, emergency contraception, intrauterine method, and sterilization. Women can opt for wide range of contraceptive options such as vaginal rings, diaphragms, female condoms, oral pills, and intra-uterine devices (IUD). Selecting the most appropriate method is critical to avoid undesired side effects.
The global Contraceptives Drugs and Devices market size was estimated at USD 28510 million in 2023 and is projected to reach USD 48167.05 million by 2032, exhibiting a CAGR of 6.00% during the forecast period.
North America Contraceptives Drugs and Devices market size was estimated at USD 8212.65 million in 2023, at a CAGR of 5.14% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Contraceptives Drugs and Devices market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Contraceptives Drugs and Devices Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Contraceptives Drugs and Devices market in any manner.
Global Contraceptives Drugs and Devices Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Teva Pharmaceutical Industries Ltd
Church & Dwight Co. Inc
Reckitt Benckiser Plc
Pfizer
Inc
Bayer AG
Mayer Laboratories
Inc
The Female Health Company
Cooper Surgical
Inc
Allergan plc
Cipla Limited
Merck & Co. Inc
Veru
Inc
Organon Group of Companies
Agile Therapeutics
TherapeuticsmMD
Inc
Afaxys
Inc
Mithra Pharmaceuticals
Abbvie
Market Segmentation (by Type)
Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
Market Segmentation (by Application)
Female
Male
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Contraceptives Drugs and Devices Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Contraceptives Drugs and Devices, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There are five widely used contraceptive methods namely barrier method, hormonal method, emergency contraception, intrauterine method, and sterilization. Women can opt for wide range of contraceptive options such as vaginal rings, diaphragms, female condoms, oral pills, and intra-uterine devices (IUD). Selecting the most appropriate method is critical to avoid undesired side effects.
The global Contraceptives Drugs and Devices market size was estimated at USD 28510 million in 2023 and is projected to reach USD 48167.05 million by 2032, exhibiting a CAGR of 6.00% during the forecast period.
North America Contraceptives Drugs and Devices market size was estimated at USD 8212.65 million in 2023, at a CAGR of 5.14% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Contraceptives Drugs and Devices market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Contraceptives Drugs and Devices Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Contraceptives Drugs and Devices market in any manner.
Global Contraceptives Drugs and Devices Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Teva Pharmaceutical Industries Ltd
Church & Dwight Co. Inc
Reckitt Benckiser Plc
Pfizer
Inc
Bayer AG
Mayer Laboratories
Inc
The Female Health Company
Cooper Surgical
Inc
Allergan plc
Cipla Limited
Merck & Co. Inc
Veru
Inc
Organon Group of Companies
Agile Therapeutics
TherapeuticsmMD
Inc
Afaxys
Inc
Mithra Pharmaceuticals
Abbvie
Market Segmentation (by Type)
Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
Market Segmentation (by Application)
Female
Male
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Contraceptives Drugs and Devices Market
- Overview of the regional outlook of the Contraceptives Drugs and Devices Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Contraceptives Drugs and Devices Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Contraceptives Drugs and Devices, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Contraceptives Drugs and Devices
1.2 Key Market Segments
1.2.1 Contraceptives Drugs and Devices Segment by Type
1.2.2 Contraceptives Drugs and Devices Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CONTRACEPTIVES DRUGS AND DEVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Contraceptives Drugs and Devices Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Contraceptives Drugs and Devices Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CONTRACEPTIVES DRUGS AND DEVICES MARKET COMPETITIVE LANDSCAPE
3.1 Global Contraceptives Drugs and Devices Sales by Manufacturers (2019-2024)
3.2 Global Contraceptives Drugs and Devices Revenue Market Share by Manufacturers (2019-2024)
3.3 Contraceptives Drugs and Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Contraceptives Drugs and Devices Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Contraceptives Drugs and Devices Sales Sites, Area Served, Product Type
3.6 Contraceptives Drugs and Devices Market Competitive Situation and Trends
3.6.1 Contraceptives Drugs and Devices Market Concentration Rate
3.6.2 Global 5 and 10 Largest Contraceptives Drugs and Devices Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CONTRACEPTIVES DRUGS AND DEVICES INDUSTRY CHAIN ANALYSIS
4.1 Contraceptives Drugs and Devices Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CONTRACEPTIVES DRUGS AND DEVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CONTRACEPTIVES DRUGS AND DEVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Contraceptives Drugs and Devices Sales Market Share by Type (2019-2024)
6.3 Global Contraceptives Drugs and Devices Market Size Market Share by Type (2019-2024)
6.4 Global Contraceptives Drugs and Devices Price by Type (2019-2024)
7 CONTRACEPTIVES DRUGS AND DEVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Contraceptives Drugs and Devices Market Sales by Application (2019-2024)
7.3 Global Contraceptives Drugs and Devices Market Size (M USD) by Application (2019-2024)
7.4 Global Contraceptives Drugs and Devices Sales Growth Rate by Application (2019-2024)
8 CONTRACEPTIVES DRUGS AND DEVICES MARKET CONSUMPTION BY REGION
8.1 Global Contraceptives Drugs and Devices Sales by Region
8.1.1 Global Contraceptives Drugs and Devices Sales by Region
8.1.2 Global Contraceptives Drugs and Devices Sales Market Share by Region
8.2 North America
8.2.1 North America Contraceptives Drugs and Devices Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Contraceptives Drugs and Devices Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Contraceptives Drugs and Devices Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Contraceptives Drugs and Devices Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Contraceptives Drugs and Devices Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 CONTRACEPTIVES DRUGS AND DEVICES MARKET PRODUCTION BY REGION
9.1 Global Production of Contraceptives Drugs and Devices by Region (2019-2024)
9.2 Global Contraceptives Drugs and Devices Revenue Market Share by Region (2019-2024)
9.3 Global Contraceptives Drugs and Devices Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Contraceptives Drugs and Devices Production
9.4.1 North America Contraceptives Drugs and Devices Production Growth Rate (2019-2024)
9.4.2 North America Contraceptives Drugs and Devices Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Contraceptives Drugs and Devices Production
9.5.1 Europe Contraceptives Drugs and Devices Production Growth Rate (2019-2024)
9.5.2 Europe Contraceptives Drugs and Devices Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Contraceptives Drugs and Devices Production (2019-2024)
9.6.1 Japan Contraceptives Drugs and Devices Production Growth Rate (2019-2024)
9.6.2 Japan Contraceptives Drugs and Devices Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Contraceptives Drugs and Devices Production (2019-2024)
9.7.1 China Contraceptives Drugs and Devices Production Growth Rate (2019-2024)
9.7.2 China Contraceptives Drugs and Devices Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Teva Pharmaceutical Industries Ltd
10.1.1 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Basic Information
10.1.2 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product Overview
10.1.3 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product Market Performance
10.1.4 Teva Pharmaceutical Industries Ltd Business Overview
10.1.5 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices SWOT Analysis
10.1.6 Teva Pharmaceutical Industries Ltd Recent Developments
10.2 Church and Dwight Co. Inc
10.2.1 Church and Dwight Co. Inc Contraceptives Drugs and Devices Basic Information
10.2.2 Church and Dwight Co. Inc Contraceptives Drugs and Devices Product Overview
10.2.3 Church and Dwight Co. Inc Contraceptives Drugs and Devices Product Market Performance
10.2.4 Church and Dwight Co. Inc Business Overview
10.2.5 Church and Dwight Co. Inc Contraceptives Drugs and Devices SWOT Analysis
10.2.6 Church and Dwight Co. Inc Recent Developments
10.3 Reckitt Benckiser Plc
10.3.1 Reckitt Benckiser Plc Contraceptives Drugs and Devices Basic Information
10.3.2 Reckitt Benckiser Plc Contraceptives Drugs and Devices Product Overview
10.3.3 Reckitt Benckiser Plc Contraceptives Drugs and Devices Product Market Performance
10.3.4 Reckitt Benckiser Plc Contraceptives Drugs and Devices SWOT Analysis
10.3.5 Reckitt Benckiser Plc Business Overview
10.3.6 Reckitt Benckiser Plc Recent Developments
10.4 Pfizer
10.4.1 Pfizer Contraceptives Drugs and Devices Basic Information
10.4.2 Pfizer Contraceptives Drugs and Devices Product Overview
10.4.3 Pfizer Contraceptives Drugs and Devices Product Market Performance
10.4.4 Pfizer Business Overview
10.4.5 Pfizer Recent Developments
10.5 Inc
10.5.1 Inc Contraceptives Drugs and Devices Basic Information
10.5.2 Inc Contraceptives Drugs and Devices Product Overview
10.5.3 Inc Contraceptives Drugs and Devices Product Market Performance
10.5.4 Inc Business Overview
10.5.5 Inc Recent Developments
10.6 Bayer AG
10.6.1 Bayer AG Contraceptives Drugs and Devices Basic Information
10.6.2 Bayer AG Contraceptives Drugs and Devices Product Overview
10.6.3 Bayer AG Contraceptives Drugs and Devices Product Market Performance
10.6.4 Bayer AG Business Overview
10.6.5 Bayer AG Recent Developments
10.7 Mayer Laboratories
10.7.1 Mayer Laboratories Contraceptives Drugs and Devices Basic Information
10.7.2 Mayer Laboratories Contraceptives Drugs and Devices Product Overview
10.7.3 Mayer Laboratories Contraceptives Drugs and Devices Product Market Performance
10.7.4 Mayer Laboratories Business Overview
10.7.5 Mayer Laboratories Recent Developments
10.8 Inc
10.8.1 Inc Contraceptives Drugs and Devices Basic Information
10.8.2 Inc Contraceptives Drugs and Devices Product Overview
10.8.3 Inc Contraceptives Drugs and Devices Product Market Performance
10.8.4 Inc Business Overview
10.8.5 Inc Recent Developments
10.9 The Female Health Company
10.9.1 The Female Health Company Contraceptives Drugs and Devices Basic Information
10.9.2 The Female Health Company Contraceptives Drugs and Devices Product Overview
10.9.3 The Female Health Company Contraceptives Drugs and Devices Product Market Performance
10.9.4 The Female Health Company Business Overview
10.9.5 The Female Health Company Recent Developments
10.10 Cooper Surgical
10.10.1 Cooper Surgical Contraceptives Drugs and Devices Basic Information
10.10.2 Cooper Surgical Contraceptives Drugs and Devices Product Overview
10.10.3 Cooper Surgical Contraceptives Drugs and Devices Product Market Performance
10.10.4 Cooper Surgical Business Overview
10.10.5 Cooper Surgical Recent Developments
10.11 Inc
10.11.1 Inc Contraceptives Drugs and Devices Basic Information
10.11.2 Inc Contraceptives Drugs and Devices Product Overview
10.11.3 Inc Contraceptives Drugs and Devices Product Market Performance
10.11.4 Inc Business Overview
10.11.5 Inc Recent Developments
10.12 Allergan plc
10.12.1 Allergan plc Contraceptives Drugs and Devices Basic Information
10.12.2 Allergan plc Contraceptives Drugs and Devices Product Overview
10.12.3 Allergan plc Contraceptives Drugs and Devices Product Market Performance
10.12.4 Allergan plc Business Overview
10.12.5 Allergan plc Recent Developments
10.13 Cipla Limited
10.13.1 Cipla Limited Contraceptives Drugs and Devices Basic Information
10.13.2 Cipla Limited Contraceptives Drugs and Devices Product Overview
10.13.3 Cipla Limited Contraceptives Drugs and Devices Product Market Performance
10.13.4 Cipla Limited Business Overview
10.13.5 Cipla Limited Recent Developments
10.14 Merck and Co. Inc
10.14.1 Merck and Co. Inc Contraceptives Drugs and Devices Basic Information
10.14.2 Merck and Co. Inc Contraceptives Drugs and Devices Product Overview
10.14.3 Merck and Co. Inc Contraceptives Drugs and Devices Product Market Performance
10.14.4 Merck and Co. Inc Business Overview
10.14.5 Merck and Co. Inc Recent Developments
10.15 Veru
10.15.1 Veru Contraceptives Drugs and Devices Basic Information
10.15.2 Veru Contraceptives Drugs and Devices Product Overview
10.15.3 Veru Contraceptives Drugs and Devices Product Market Performance
10.15.4 Veru Business Overview
10.15.5 Veru Recent Developments
10.16 Inc
10.16.1 Inc Contraceptives Drugs and Devices Basic Information
10.16.2 Inc Contraceptives Drugs and Devices Product Overview
10.16.3 Inc Contraceptives Drugs and Devices Product Market Performance
10.16.4 Inc Business Overview
10.16.5 Inc Recent Developments
10.17 Organon Group of Companies
10.17.1 Organon Group of Companies Contraceptives Drugs and Devices Basic Information
10.17.2 Organon Group of Companies Contraceptives Drugs and Devices Product Overview
10.17.3 Organon Group of Companies Contraceptives Drugs and Devices Product Market Performance
10.17.4 Organon Group of Companies Business Overview
10.17.5 Organon Group of Companies Recent Developments
10.18 Agile Therapeutics
10.18.1 Agile Therapeutics Contraceptives Drugs and Devices Basic Information
10.18.2 Agile Therapeutics Contraceptives Drugs and Devices Product Overview
10.18.3 Agile Therapeutics Contraceptives Drugs and Devices Product Market Performance
10.18.4 Agile Therapeutics Business Overview
10.18.5 Agile Therapeutics Recent Developments
10.19 TherapeuticsmMD
10.19.1 TherapeuticsmMD Contraceptives Drugs and Devices Basic Information
10.19.2 TherapeuticsmMD Contraceptives Drugs and Devices Product Overview
10.19.3 TherapeuticsmMD Contraceptives Drugs and Devices Product Market Performance
10.19.4 TherapeuticsmMD Business Overview
10.19.5 TherapeuticsmMD Recent Developments
10.20 Inc
10.20.1 Inc Contraceptives Drugs and Devices Basic Information
10.20.2 Inc Contraceptives Drugs and Devices Product Overview
10.20.3 Inc Contraceptives Drugs and Devices Product Market Performance
10.20.4 Inc Business Overview
10.20.5 Inc Recent Developments
10.21 Afaxys
10.21.1 Afaxys Contraceptives Drugs and Devices Basic Information
10.21.2 Afaxys Contraceptives Drugs and Devices Product Overview
10.21.3 Afaxys Contraceptives Drugs and Devices Product Market Performance
10.21.4 Afaxys Business Overview
10.21.5 Afaxys Recent Developments
10.22 Inc
10.22.1 Inc Contraceptives Drugs and Devices Basic Information
10.22.2 Inc Contraceptives Drugs and Devices Product Overview
10.22.3 Inc Contraceptives Drugs and Devices Product Market Performance
10.22.4 Inc Business Overview
10.22.5 Inc Recent Developments
10.23 Mithra Pharmaceuticals
10.23.1 Mithra Pharmaceuticals Contraceptives Drugs and Devices Basic Information
10.23.2 Mithra Pharmaceuticals Contraceptives Drugs and Devices Product Overview
10.23.3 Mithra Pharmaceuticals Contraceptives Drugs and Devices Product Market Performance
10.23.4 Mithra Pharmaceuticals Business Overview
10.23.5 Mithra Pharmaceuticals Recent Developments
10.24 Abbvie
10.24.1 Abbvie Contraceptives Drugs and Devices Basic Information
10.24.2 Abbvie Contraceptives Drugs and Devices Product Overview
10.24.3 Abbvie Contraceptives Drugs and Devices Product Market Performance
10.24.4 Abbvie Business Overview
10.24.5 Abbvie Recent Developments
11 CONTRACEPTIVES DRUGS AND DEVICES MARKET FORECAST BY REGION
11.1 Global Contraceptives Drugs and Devices Market Size Forecast
11.2 Global Contraceptives Drugs and Devices Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Contraceptives Drugs and Devices Market Size Forecast by Country
11.2.3 Asia Pacific Contraceptives Drugs and Devices Market Size Forecast by Region
11.2.4 South America Contraceptives Drugs and Devices Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Contraceptives Drugs and Devices by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Contraceptives Drugs and Devices Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Contraceptives Drugs and Devices by Type (2025-2032)
12.1.2 Global Contraceptives Drugs and Devices Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Contraceptives Drugs and Devices by Type (2025-2032)
12.2 Global Contraceptives Drugs and Devices Market Forecast by Application (2025-2032)
12.2.1 Global Contraceptives Drugs and Devices Sales (K Units) Forecast by Application
12.2.2 Global Contraceptives Drugs and Devices Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Contraceptives Drugs and Devices
1.2 Key Market Segments
1.2.1 Contraceptives Drugs and Devices Segment by Type
1.2.2 Contraceptives Drugs and Devices Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CONTRACEPTIVES DRUGS AND DEVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Contraceptives Drugs and Devices Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Contraceptives Drugs and Devices Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CONTRACEPTIVES DRUGS AND DEVICES MARKET COMPETITIVE LANDSCAPE
3.1 Global Contraceptives Drugs and Devices Sales by Manufacturers (2019-2024)
3.2 Global Contraceptives Drugs and Devices Revenue Market Share by Manufacturers (2019-2024)
3.3 Contraceptives Drugs and Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Contraceptives Drugs and Devices Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Contraceptives Drugs and Devices Sales Sites, Area Served, Product Type
3.6 Contraceptives Drugs and Devices Market Competitive Situation and Trends
3.6.1 Contraceptives Drugs and Devices Market Concentration Rate
3.6.2 Global 5 and 10 Largest Contraceptives Drugs and Devices Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CONTRACEPTIVES DRUGS AND DEVICES INDUSTRY CHAIN ANALYSIS
4.1 Contraceptives Drugs and Devices Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CONTRACEPTIVES DRUGS AND DEVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CONTRACEPTIVES DRUGS AND DEVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Contraceptives Drugs and Devices Sales Market Share by Type (2019-2024)
6.3 Global Contraceptives Drugs and Devices Market Size Market Share by Type (2019-2024)
6.4 Global Contraceptives Drugs and Devices Price by Type (2019-2024)
7 CONTRACEPTIVES DRUGS AND DEVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Contraceptives Drugs and Devices Market Sales by Application (2019-2024)
7.3 Global Contraceptives Drugs and Devices Market Size (M USD) by Application (2019-2024)
7.4 Global Contraceptives Drugs and Devices Sales Growth Rate by Application (2019-2024)
8 CONTRACEPTIVES DRUGS AND DEVICES MARKET CONSUMPTION BY REGION
8.1 Global Contraceptives Drugs and Devices Sales by Region
8.1.1 Global Contraceptives Drugs and Devices Sales by Region
8.1.2 Global Contraceptives Drugs and Devices Sales Market Share by Region
8.2 North America
8.2.1 North America Contraceptives Drugs and Devices Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Contraceptives Drugs and Devices Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Contraceptives Drugs and Devices Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Contraceptives Drugs and Devices Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Contraceptives Drugs and Devices Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 CONTRACEPTIVES DRUGS AND DEVICES MARKET PRODUCTION BY REGION
9.1 Global Production of Contraceptives Drugs and Devices by Region (2019-2024)
9.2 Global Contraceptives Drugs and Devices Revenue Market Share by Region (2019-2024)
9.3 Global Contraceptives Drugs and Devices Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Contraceptives Drugs and Devices Production
9.4.1 North America Contraceptives Drugs and Devices Production Growth Rate (2019-2024)
9.4.2 North America Contraceptives Drugs and Devices Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Contraceptives Drugs and Devices Production
9.5.1 Europe Contraceptives Drugs and Devices Production Growth Rate (2019-2024)
9.5.2 Europe Contraceptives Drugs and Devices Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Contraceptives Drugs and Devices Production (2019-2024)
9.6.1 Japan Contraceptives Drugs and Devices Production Growth Rate (2019-2024)
9.6.2 Japan Contraceptives Drugs and Devices Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Contraceptives Drugs and Devices Production (2019-2024)
9.7.1 China Contraceptives Drugs and Devices Production Growth Rate (2019-2024)
9.7.2 China Contraceptives Drugs and Devices Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Teva Pharmaceutical Industries Ltd
10.1.1 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Basic Information
10.1.2 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product Overview
10.1.3 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product Market Performance
10.1.4 Teva Pharmaceutical Industries Ltd Business Overview
10.1.5 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices SWOT Analysis
10.1.6 Teva Pharmaceutical Industries Ltd Recent Developments
10.2 Church and Dwight Co. Inc
10.2.1 Church and Dwight Co. Inc Contraceptives Drugs and Devices Basic Information
10.2.2 Church and Dwight Co. Inc Contraceptives Drugs and Devices Product Overview
10.2.3 Church and Dwight Co. Inc Contraceptives Drugs and Devices Product Market Performance
10.2.4 Church and Dwight Co. Inc Business Overview
10.2.5 Church and Dwight Co. Inc Contraceptives Drugs and Devices SWOT Analysis
10.2.6 Church and Dwight Co. Inc Recent Developments
10.3 Reckitt Benckiser Plc
10.3.1 Reckitt Benckiser Plc Contraceptives Drugs and Devices Basic Information
10.3.2 Reckitt Benckiser Plc Contraceptives Drugs and Devices Product Overview
10.3.3 Reckitt Benckiser Plc Contraceptives Drugs and Devices Product Market Performance
10.3.4 Reckitt Benckiser Plc Contraceptives Drugs and Devices SWOT Analysis
10.3.5 Reckitt Benckiser Plc Business Overview
10.3.6 Reckitt Benckiser Plc Recent Developments
10.4 Pfizer
10.4.1 Pfizer Contraceptives Drugs and Devices Basic Information
10.4.2 Pfizer Contraceptives Drugs and Devices Product Overview
10.4.3 Pfizer Contraceptives Drugs and Devices Product Market Performance
10.4.4 Pfizer Business Overview
10.4.5 Pfizer Recent Developments
10.5 Inc
10.5.1 Inc Contraceptives Drugs and Devices Basic Information
10.5.2 Inc Contraceptives Drugs and Devices Product Overview
10.5.3 Inc Contraceptives Drugs and Devices Product Market Performance
10.5.4 Inc Business Overview
10.5.5 Inc Recent Developments
10.6 Bayer AG
10.6.1 Bayer AG Contraceptives Drugs and Devices Basic Information
10.6.2 Bayer AG Contraceptives Drugs and Devices Product Overview
10.6.3 Bayer AG Contraceptives Drugs and Devices Product Market Performance
10.6.4 Bayer AG Business Overview
10.6.5 Bayer AG Recent Developments
10.7 Mayer Laboratories
10.7.1 Mayer Laboratories Contraceptives Drugs and Devices Basic Information
10.7.2 Mayer Laboratories Contraceptives Drugs and Devices Product Overview
10.7.3 Mayer Laboratories Contraceptives Drugs and Devices Product Market Performance
10.7.4 Mayer Laboratories Business Overview
10.7.5 Mayer Laboratories Recent Developments
10.8 Inc
10.8.1 Inc Contraceptives Drugs and Devices Basic Information
10.8.2 Inc Contraceptives Drugs and Devices Product Overview
10.8.3 Inc Contraceptives Drugs and Devices Product Market Performance
10.8.4 Inc Business Overview
10.8.5 Inc Recent Developments
10.9 The Female Health Company
10.9.1 The Female Health Company Contraceptives Drugs and Devices Basic Information
10.9.2 The Female Health Company Contraceptives Drugs and Devices Product Overview
10.9.3 The Female Health Company Contraceptives Drugs and Devices Product Market Performance
10.9.4 The Female Health Company Business Overview
10.9.5 The Female Health Company Recent Developments
10.10 Cooper Surgical
10.10.1 Cooper Surgical Contraceptives Drugs and Devices Basic Information
10.10.2 Cooper Surgical Contraceptives Drugs and Devices Product Overview
10.10.3 Cooper Surgical Contraceptives Drugs and Devices Product Market Performance
10.10.4 Cooper Surgical Business Overview
10.10.5 Cooper Surgical Recent Developments
10.11 Inc
10.11.1 Inc Contraceptives Drugs and Devices Basic Information
10.11.2 Inc Contraceptives Drugs and Devices Product Overview
10.11.3 Inc Contraceptives Drugs and Devices Product Market Performance
10.11.4 Inc Business Overview
10.11.5 Inc Recent Developments
10.12 Allergan plc
10.12.1 Allergan plc Contraceptives Drugs and Devices Basic Information
10.12.2 Allergan plc Contraceptives Drugs and Devices Product Overview
10.12.3 Allergan plc Contraceptives Drugs and Devices Product Market Performance
10.12.4 Allergan plc Business Overview
10.12.5 Allergan plc Recent Developments
10.13 Cipla Limited
10.13.1 Cipla Limited Contraceptives Drugs and Devices Basic Information
10.13.2 Cipla Limited Contraceptives Drugs and Devices Product Overview
10.13.3 Cipla Limited Contraceptives Drugs and Devices Product Market Performance
10.13.4 Cipla Limited Business Overview
10.13.5 Cipla Limited Recent Developments
10.14 Merck and Co. Inc
10.14.1 Merck and Co. Inc Contraceptives Drugs and Devices Basic Information
10.14.2 Merck and Co. Inc Contraceptives Drugs and Devices Product Overview
10.14.3 Merck and Co. Inc Contraceptives Drugs and Devices Product Market Performance
10.14.4 Merck and Co. Inc Business Overview
10.14.5 Merck and Co. Inc Recent Developments
10.15 Veru
10.15.1 Veru Contraceptives Drugs and Devices Basic Information
10.15.2 Veru Contraceptives Drugs and Devices Product Overview
10.15.3 Veru Contraceptives Drugs and Devices Product Market Performance
10.15.4 Veru Business Overview
10.15.5 Veru Recent Developments
10.16 Inc
10.16.1 Inc Contraceptives Drugs and Devices Basic Information
10.16.2 Inc Contraceptives Drugs and Devices Product Overview
10.16.3 Inc Contraceptives Drugs and Devices Product Market Performance
10.16.4 Inc Business Overview
10.16.5 Inc Recent Developments
10.17 Organon Group of Companies
10.17.1 Organon Group of Companies Contraceptives Drugs and Devices Basic Information
10.17.2 Organon Group of Companies Contraceptives Drugs and Devices Product Overview
10.17.3 Organon Group of Companies Contraceptives Drugs and Devices Product Market Performance
10.17.4 Organon Group of Companies Business Overview
10.17.5 Organon Group of Companies Recent Developments
10.18 Agile Therapeutics
10.18.1 Agile Therapeutics Contraceptives Drugs and Devices Basic Information
10.18.2 Agile Therapeutics Contraceptives Drugs and Devices Product Overview
10.18.3 Agile Therapeutics Contraceptives Drugs and Devices Product Market Performance
10.18.4 Agile Therapeutics Business Overview
10.18.5 Agile Therapeutics Recent Developments
10.19 TherapeuticsmMD
10.19.1 TherapeuticsmMD Contraceptives Drugs and Devices Basic Information
10.19.2 TherapeuticsmMD Contraceptives Drugs and Devices Product Overview
10.19.3 TherapeuticsmMD Contraceptives Drugs and Devices Product Market Performance
10.19.4 TherapeuticsmMD Business Overview
10.19.5 TherapeuticsmMD Recent Developments
10.20 Inc
10.20.1 Inc Contraceptives Drugs and Devices Basic Information
10.20.2 Inc Contraceptives Drugs and Devices Product Overview
10.20.3 Inc Contraceptives Drugs and Devices Product Market Performance
10.20.4 Inc Business Overview
10.20.5 Inc Recent Developments
10.21 Afaxys
10.21.1 Afaxys Contraceptives Drugs and Devices Basic Information
10.21.2 Afaxys Contraceptives Drugs and Devices Product Overview
10.21.3 Afaxys Contraceptives Drugs and Devices Product Market Performance
10.21.4 Afaxys Business Overview
10.21.5 Afaxys Recent Developments
10.22 Inc
10.22.1 Inc Contraceptives Drugs and Devices Basic Information
10.22.2 Inc Contraceptives Drugs and Devices Product Overview
10.22.3 Inc Contraceptives Drugs and Devices Product Market Performance
10.22.4 Inc Business Overview
10.22.5 Inc Recent Developments
10.23 Mithra Pharmaceuticals
10.23.1 Mithra Pharmaceuticals Contraceptives Drugs and Devices Basic Information
10.23.2 Mithra Pharmaceuticals Contraceptives Drugs and Devices Product Overview
10.23.3 Mithra Pharmaceuticals Contraceptives Drugs and Devices Product Market Performance
10.23.4 Mithra Pharmaceuticals Business Overview
10.23.5 Mithra Pharmaceuticals Recent Developments
10.24 Abbvie
10.24.1 Abbvie Contraceptives Drugs and Devices Basic Information
10.24.2 Abbvie Contraceptives Drugs and Devices Product Overview
10.24.3 Abbvie Contraceptives Drugs and Devices Product Market Performance
10.24.4 Abbvie Business Overview
10.24.5 Abbvie Recent Developments
11 CONTRACEPTIVES DRUGS AND DEVICES MARKET FORECAST BY REGION
11.1 Global Contraceptives Drugs and Devices Market Size Forecast
11.2 Global Contraceptives Drugs and Devices Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Contraceptives Drugs and Devices Market Size Forecast by Country
11.2.3 Asia Pacific Contraceptives Drugs and Devices Market Size Forecast by Region
11.2.4 South America Contraceptives Drugs and Devices Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Contraceptives Drugs and Devices by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Contraceptives Drugs and Devices Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Contraceptives Drugs and Devices by Type (2025-2032)
12.1.2 Global Contraceptives Drugs and Devices Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Contraceptives Drugs and Devices by Type (2025-2032)
12.2 Global Contraceptives Drugs and Devices Market Forecast by Application (2025-2032)
12.2.1 Global Contraceptives Drugs and Devices Sales (K Units) Forecast by Application
12.2.2 Global Contraceptives Drugs and Devices Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Contraceptives Drugs and Devices Market Size Comparison by Region (M USD)
Table 5. Global Contraceptives Drugs and Devices Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Contraceptives Drugs and Devices Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Contraceptives Drugs and Devices Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Contraceptives Drugs and Devices Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contraceptives Drugs and Devices as of 2022)
Table 10. Global Market Contraceptives Drugs and Devices Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Contraceptives Drugs and Devices Sales Sites and Area Served
Table 12. Manufacturers Contraceptives Drugs and Devices Product Type
Table 13. Global Contraceptives Drugs and Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Contraceptives Drugs and Devices
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Contraceptives Drugs and Devices Market Challenges
Table 22. Global Contraceptives Drugs and Devices Sales by Type (K Units)
Table 23. Global Contraceptives Drugs and Devices Market Size by Type (M USD)
Table 24. Global Contraceptives Drugs and Devices Sales (K Units) by Type (2019-2024)
Table 25. Global Contraceptives Drugs and Devices Sales Market Share by Type (2019-2024)
Table 26. Global Contraceptives Drugs and Devices Market Size (M USD) by Type (2019-2024)
Table 27. Global Contraceptives Drugs and Devices Market Size Share by Type (2019-2024)
Table 28. Global Contraceptives Drugs and Devices Price (USD/Unit) by Type (2019-2024)
Table 29. Global Contraceptives Drugs and Devices Sales (K Units) by Application
Table 30. Global Contraceptives Drugs and Devices Market Size by Application
Table 31. Global Contraceptives Drugs and Devices Sales by Application (2019-2024) & (K Units)
Table 32. Global Contraceptives Drugs and Devices Sales Market Share by Application (2019-2024)
Table 33. Global Contraceptives Drugs and Devices Sales by Application (2019-2024) & (M USD)
Table 34. Global Contraceptives Drugs and Devices Market Share by Application (2019-2024)
Table 35. Global Contraceptives Drugs and Devices Sales Growth Rate by Application (2019-2024)
Table 36. Global Contraceptives Drugs and Devices Sales by Region (2019-2024) & (K Units)
Table 37. Global Contraceptives Drugs and Devices Sales Market Share by Region (2019-2024)
Table 38. North America Contraceptives Drugs and Devices Sales by Country (2019-2024) & (K Units)
Table 39. Europe Contraceptives Drugs and Devices Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Contraceptives Drugs and Devices Sales by Region (2019-2024) & (K Units)
Table 41. South America Contraceptives Drugs and Devices Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Contraceptives Drugs and Devices Sales by Region (2019-2024) & (K Units)
Table 43. Global Contraceptives Drugs and Devices Production (K Units) by Region (2019-2024)
Table 44. Global Contraceptives Drugs and Devices Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Contraceptives Drugs and Devices Revenue Market Share by Region (2019-2024)
Table 46. Global Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Basic Information
Table 52. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product Overview
Table 53. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Teva Pharmaceutical Industries Ltd Business Overview
Table 55. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices SWOT Analysis
Table 56. Teva Pharmaceutical Industries Ltd Recent Developments
Table 57. Church and Dwight Co. Inc Contraceptives Drugs and Devices Basic Information
Table 58. Church and Dwight Co. Inc Contraceptives Drugs and Devices Product Overview
Table 59. Church and Dwight Co. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Church and Dwight Co. Inc Business Overview
Table 61. Church and Dwight Co. Inc Contraceptives Drugs and Devices SWOT Analysis
Table 62. Church and Dwight Co. Inc Recent Developments
Table 63. Reckitt Benckiser Plc Contraceptives Drugs and Devices Basic Information
Table 64. Reckitt Benckiser Plc Contraceptives Drugs and Devices Product Overview
Table 65. Reckitt Benckiser Plc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. Reckitt Benckiser Plc Contraceptives Drugs and Devices SWOT Analysis
Table 67. Reckitt Benckiser Plc Business Overview
Table 68. Reckitt Benckiser Plc Recent Developments
Table 69. Pfizer Contraceptives Drugs and Devices Basic Information
Table 70. Pfizer Contraceptives Drugs and Devices Product Overview
Table 71. Pfizer Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. Pfizer Business Overview
Table 73. Pfizer Recent Developments
Table 74. Inc Contraceptives Drugs and Devices Basic Information
Table 75. Inc Contraceptives Drugs and Devices Product Overview
Table 76. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Inc Business Overview
Table 78. Inc Recent Developments
Table 79. Bayer AG Contraceptives Drugs and Devices Basic Information
Table 80. Bayer AG Contraceptives Drugs and Devices Product Overview
Table 81. Bayer AG Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Bayer AG Business Overview
Table 83. Bayer AG Recent Developments
Table 84. Mayer Laboratories Contraceptives Drugs and Devices Basic Information
Table 85. Mayer Laboratories Contraceptives Drugs and Devices Product Overview
Table 86. Mayer Laboratories Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Mayer Laboratories Business Overview
Table 88. Mayer Laboratories Recent Developments
Table 89. Inc Contraceptives Drugs and Devices Basic Information
Table 90. Inc Contraceptives Drugs and Devices Product Overview
Table 91. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Inc Business Overview
Table 93. Inc Recent Developments
Table 94. The Female Health Company Contraceptives Drugs and Devices Basic Information
Table 95. The Female Health Company Contraceptives Drugs and Devices Product Overview
Table 96. The Female Health Company Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. The Female Health Company Business Overview
Table 98. The Female Health Company Recent Developments
Table 99. Cooper Surgical Contraceptives Drugs and Devices Basic Information
Table 100. Cooper Surgical Contraceptives Drugs and Devices Product Overview
Table 101. Cooper Surgical Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Cooper Surgical Business Overview
Table 103. Cooper Surgical Recent Developments
Table 104. Inc Contraceptives Drugs and Devices Basic Information
Table 105. Inc Contraceptives Drugs and Devices Product Overview
Table 106. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Inc Business Overview
Table 108. Inc Recent Developments
Table 109. Allergan plc Contraceptives Drugs and Devices Basic Information
Table 110. Allergan plc Contraceptives Drugs and Devices Product Overview
Table 111. Allergan plc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Allergan plc Business Overview
Table 113. Allergan plc Recent Developments
Table 114. Cipla Limited Contraceptives Drugs and Devices Basic Information
Table 115. Cipla Limited Contraceptives Drugs and Devices Product Overview
Table 116. Cipla Limited Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. Cipla Limited Business Overview
Table 118. Cipla Limited Recent Developments
Table 119. Merck and Co. Inc Contraceptives Drugs and Devices Basic Information
Table 120. Merck and Co. Inc Contraceptives Drugs and Devices Product Overview
Table 121. Merck and Co. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Merck and Co. Inc Business Overview
Table 123. Merck and Co. Inc Recent Developments
Table 124. Veru Contraceptives Drugs and Devices Basic Information
Table 125. Veru Contraceptives Drugs and Devices Product Overview
Table 126. Veru Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 127. Veru Business Overview
Table 128. Veru Recent Developments
Table 129. Inc Contraceptives Drugs and Devices Basic Information
Table 130. Inc Contraceptives Drugs and Devices Product Overview
Table 131. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 132. Inc Business Overview
Table 133. Inc Recent Developments
Table 134. Organon Group of Companies Contraceptives Drugs and Devices Basic Information
Table 135. Organon Group of Companies Contraceptives Drugs and Devices Product Overview
Table 136. Organon Group of Companies Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 137. Organon Group of Companies Business Overview
Table 138. Organon Group of Companies Recent Developments
Table 139. Agile Therapeutics Contraceptives Drugs and Devices Basic Information
Table 140. Agile Therapeutics Contraceptives Drugs and Devices Product Overview
Table 141. Agile Therapeutics Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 142. Agile Therapeutics Business Overview
Table 143. Agile Therapeutics Recent Developments
Table 144. TherapeuticsmMD Contraceptives Drugs and Devices Basic Information
Table 145. TherapeuticsmMD Contraceptives Drugs and Devices Product Overview
Table 146. TherapeuticsmMD Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 147. TherapeuticsmMD Business Overview
Table 148. TherapeuticsmMD Recent Developments
Table 149. Inc Contraceptives Drugs and Devices Basic Information
Table 150. Inc Contraceptives Drugs and Devices Product Overview
Table 151. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 152. Inc Business Overview
Table 153. Inc Recent Developments
Table 154. Afaxys Contraceptives Drugs and Devices Basic Information
Table 155. Afaxys Contraceptives Drugs and Devices Product Overview
Table 156. Afaxys Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 157. Afaxys Business Overview
Table 158. Afaxys Recent Developments
Table 159. Inc Contraceptives Drugs and Devices Basic Information
Table 160. Inc Contraceptives Drugs and Devices Product Overview
Table 161. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 162. Inc Business Overview
Table 163. Inc Recent Developments
Table 164. Mithra Pharmaceuticals Contraceptives Drugs and Devices Basic Information
Table 165. Mithra Pharmaceuticals Contraceptives Drugs and Devices Product Overview
Table 166. Mithra Pharmaceuticals Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 167. Mithra Pharmaceuticals Business Overview
Table 168. Mithra Pharmaceuticals Recent Developments
Table 169. Abbvie Contraceptives Drugs and Devices Basic Information
Table 170. Abbvie Contraceptives Drugs and Devices Product Overview
Table 171. Abbvie Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 172. Abbvie Business Overview
Table 173. Abbvie Recent Developments
Table 174. Global Contraceptives Drugs and Devices Sales Forecast by Region (2025-2032) & (K Units)
Table 175. Global Contraceptives Drugs and Devices Market Size Forecast by Region (2025-2032) & (M USD)
Table 176. North America Contraceptives Drugs and Devices Sales Forecast by Country (2025-2032) & (K Units)
Table 177. North America Contraceptives Drugs and Devices Market Size Forecast by Country (2025-2032) & (M USD)
Table 178. Europe Contraceptives Drugs and Devices Sales Forecast by Country (2025-2032) & (K Units)
Table 179. Europe Contraceptives Drugs and Devices Market Size Forecast by Country (2025-2032) & (M USD)
Table 180. Asia Pacific Contraceptives Drugs and Devices Sales Forecast by Region (2025-2032) & (K Units)
Table 181. Asia Pacific Contraceptives Drugs and Devices Market Size Forecast by Region (2025-2032) & (M USD)
Table 182. South America Contraceptives Drugs and Devices Sales Forecast by Country (2025-2032) & (K Units)
Table 183. South America Contraceptives Drugs and Devices Market Size Forecast by Country (2025-2032) & (M USD)
Table 184. Middle East and Africa Contraceptives Drugs and Devices Consumption Forecast by Country (2025-2032) & (Units)
Table 185. Middle East and Africa Contraceptives Drugs and Devices Market Size Forecast by Country (2025-2032) & (M USD)
Table 186. Global Contraceptives Drugs and Devices Sales Forecast by Type (2025-2032) & (K Units)
Table 187. Global Contraceptives Drugs and Devices Market Size Forecast by Type (2025-2032) & (M USD)
Table 188. Global Contraceptives Drugs and Devices Price Forecast by Type (2025-2032) & (USD/Unit)
Table 189. Global Contraceptives Drugs and Devices Sales (K Units) Forecast by Application (2025-2032)
Table 190. Global Contraceptives Drugs and Devices Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Contraceptives Drugs and Devices Market Size Comparison by Region (M USD)
Table 5. Global Contraceptives Drugs and Devices Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Contraceptives Drugs and Devices Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Contraceptives Drugs and Devices Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Contraceptives Drugs and Devices Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contraceptives Drugs and Devices as of 2022)
Table 10. Global Market Contraceptives Drugs and Devices Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Contraceptives Drugs and Devices Sales Sites and Area Served
Table 12. Manufacturers Contraceptives Drugs and Devices Product Type
Table 13. Global Contraceptives Drugs and Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Contraceptives Drugs and Devices
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Contraceptives Drugs and Devices Market Challenges
Table 22. Global Contraceptives Drugs and Devices Sales by Type (K Units)
Table 23. Global Contraceptives Drugs and Devices Market Size by Type (M USD)
Table 24. Global Contraceptives Drugs and Devices Sales (K Units) by Type (2019-2024)
Table 25. Global Contraceptives Drugs and Devices Sales Market Share by Type (2019-2024)
Table 26. Global Contraceptives Drugs and Devices Market Size (M USD) by Type (2019-2024)
Table 27. Global Contraceptives Drugs and Devices Market Size Share by Type (2019-2024)
Table 28. Global Contraceptives Drugs and Devices Price (USD/Unit) by Type (2019-2024)
Table 29. Global Contraceptives Drugs and Devices Sales (K Units) by Application
Table 30. Global Contraceptives Drugs and Devices Market Size by Application
Table 31. Global Contraceptives Drugs and Devices Sales by Application (2019-2024) & (K Units)
Table 32. Global Contraceptives Drugs and Devices Sales Market Share by Application (2019-2024)
Table 33. Global Contraceptives Drugs and Devices Sales by Application (2019-2024) & (M USD)
Table 34. Global Contraceptives Drugs and Devices Market Share by Application (2019-2024)
Table 35. Global Contraceptives Drugs and Devices Sales Growth Rate by Application (2019-2024)
Table 36. Global Contraceptives Drugs and Devices Sales by Region (2019-2024) & (K Units)
Table 37. Global Contraceptives Drugs and Devices Sales Market Share by Region (2019-2024)
Table 38. North America Contraceptives Drugs and Devices Sales by Country (2019-2024) & (K Units)
Table 39. Europe Contraceptives Drugs and Devices Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Contraceptives Drugs and Devices Sales by Region (2019-2024) & (K Units)
Table 41. South America Contraceptives Drugs and Devices Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Contraceptives Drugs and Devices Sales by Region (2019-2024) & (K Units)
Table 43. Global Contraceptives Drugs and Devices Production (K Units) by Region (2019-2024)
Table 44. Global Contraceptives Drugs and Devices Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Contraceptives Drugs and Devices Revenue Market Share by Region (2019-2024)
Table 46. Global Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Basic Information
Table 52. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product Overview
Table 53. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Teva Pharmaceutical Industries Ltd Business Overview
Table 55. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices SWOT Analysis
Table 56. Teva Pharmaceutical Industries Ltd Recent Developments
Table 57. Church and Dwight Co. Inc Contraceptives Drugs and Devices Basic Information
Table 58. Church and Dwight Co. Inc Contraceptives Drugs and Devices Product Overview
Table 59. Church and Dwight Co. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Church and Dwight Co. Inc Business Overview
Table 61. Church and Dwight Co. Inc Contraceptives Drugs and Devices SWOT Analysis
Table 62. Church and Dwight Co. Inc Recent Developments
Table 63. Reckitt Benckiser Plc Contraceptives Drugs and Devices Basic Information
Table 64. Reckitt Benckiser Plc Contraceptives Drugs and Devices Product Overview
Table 65. Reckitt Benckiser Plc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. Reckitt Benckiser Plc Contraceptives Drugs and Devices SWOT Analysis
Table 67. Reckitt Benckiser Plc Business Overview
Table 68. Reckitt Benckiser Plc Recent Developments
Table 69. Pfizer Contraceptives Drugs and Devices Basic Information
Table 70. Pfizer Contraceptives Drugs and Devices Product Overview
Table 71. Pfizer Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. Pfizer Business Overview
Table 73. Pfizer Recent Developments
Table 74. Inc Contraceptives Drugs and Devices Basic Information
Table 75. Inc Contraceptives Drugs and Devices Product Overview
Table 76. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Inc Business Overview
Table 78. Inc Recent Developments
Table 79. Bayer AG Contraceptives Drugs and Devices Basic Information
Table 80. Bayer AG Contraceptives Drugs and Devices Product Overview
Table 81. Bayer AG Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Bayer AG Business Overview
Table 83. Bayer AG Recent Developments
Table 84. Mayer Laboratories Contraceptives Drugs and Devices Basic Information
Table 85. Mayer Laboratories Contraceptives Drugs and Devices Product Overview
Table 86. Mayer Laboratories Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Mayer Laboratories Business Overview
Table 88. Mayer Laboratories Recent Developments
Table 89. Inc Contraceptives Drugs and Devices Basic Information
Table 90. Inc Contraceptives Drugs and Devices Product Overview
Table 91. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Inc Business Overview
Table 93. Inc Recent Developments
Table 94. The Female Health Company Contraceptives Drugs and Devices Basic Information
Table 95. The Female Health Company Contraceptives Drugs and Devices Product Overview
Table 96. The Female Health Company Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. The Female Health Company Business Overview
Table 98. The Female Health Company Recent Developments
Table 99. Cooper Surgical Contraceptives Drugs and Devices Basic Information
Table 100. Cooper Surgical Contraceptives Drugs and Devices Product Overview
Table 101. Cooper Surgical Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Cooper Surgical Business Overview
Table 103. Cooper Surgical Recent Developments
Table 104. Inc Contraceptives Drugs and Devices Basic Information
Table 105. Inc Contraceptives Drugs and Devices Product Overview
Table 106. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Inc Business Overview
Table 108. Inc Recent Developments
Table 109. Allergan plc Contraceptives Drugs and Devices Basic Information
Table 110. Allergan plc Contraceptives Drugs and Devices Product Overview
Table 111. Allergan plc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Allergan plc Business Overview
Table 113. Allergan plc Recent Developments
Table 114. Cipla Limited Contraceptives Drugs and Devices Basic Information
Table 115. Cipla Limited Contraceptives Drugs and Devices Product Overview
Table 116. Cipla Limited Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. Cipla Limited Business Overview
Table 118. Cipla Limited Recent Developments
Table 119. Merck and Co. Inc Contraceptives Drugs and Devices Basic Information
Table 120. Merck and Co. Inc Contraceptives Drugs and Devices Product Overview
Table 121. Merck and Co. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Merck and Co. Inc Business Overview
Table 123. Merck and Co. Inc Recent Developments
Table 124. Veru Contraceptives Drugs and Devices Basic Information
Table 125. Veru Contraceptives Drugs and Devices Product Overview
Table 126. Veru Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 127. Veru Business Overview
Table 128. Veru Recent Developments
Table 129. Inc Contraceptives Drugs and Devices Basic Information
Table 130. Inc Contraceptives Drugs and Devices Product Overview
Table 131. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 132. Inc Business Overview
Table 133. Inc Recent Developments
Table 134. Organon Group of Companies Contraceptives Drugs and Devices Basic Information
Table 135. Organon Group of Companies Contraceptives Drugs and Devices Product Overview
Table 136. Organon Group of Companies Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 137. Organon Group of Companies Business Overview
Table 138. Organon Group of Companies Recent Developments
Table 139. Agile Therapeutics Contraceptives Drugs and Devices Basic Information
Table 140. Agile Therapeutics Contraceptives Drugs and Devices Product Overview
Table 141. Agile Therapeutics Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 142. Agile Therapeutics Business Overview
Table 143. Agile Therapeutics Recent Developments
Table 144. TherapeuticsmMD Contraceptives Drugs and Devices Basic Information
Table 145. TherapeuticsmMD Contraceptives Drugs and Devices Product Overview
Table 146. TherapeuticsmMD Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 147. TherapeuticsmMD Business Overview
Table 148. TherapeuticsmMD Recent Developments
Table 149. Inc Contraceptives Drugs and Devices Basic Information
Table 150. Inc Contraceptives Drugs and Devices Product Overview
Table 151. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 152. Inc Business Overview
Table 153. Inc Recent Developments
Table 154. Afaxys Contraceptives Drugs and Devices Basic Information
Table 155. Afaxys Contraceptives Drugs and Devices Product Overview
Table 156. Afaxys Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 157. Afaxys Business Overview
Table 158. Afaxys Recent Developments
Table 159. Inc Contraceptives Drugs and Devices Basic Information
Table 160. Inc Contraceptives Drugs and Devices Product Overview
Table 161. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 162. Inc Business Overview
Table 163. Inc Recent Developments
Table 164. Mithra Pharmaceuticals Contraceptives Drugs and Devices Basic Information
Table 165. Mithra Pharmaceuticals Contraceptives Drugs and Devices Product Overview
Table 166. Mithra Pharmaceuticals Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 167. Mithra Pharmaceuticals Business Overview
Table 168. Mithra Pharmaceuticals Recent Developments
Table 169. Abbvie Contraceptives Drugs and Devices Basic Information
Table 170. Abbvie Contraceptives Drugs and Devices Product Overview
Table 171. Abbvie Contraceptives Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 172. Abbvie Business Overview
Table 173. Abbvie Recent Developments
Table 174. Global Contraceptives Drugs and Devices Sales Forecast by Region (2025-2032) & (K Units)
Table 175. Global Contraceptives Drugs and Devices Market Size Forecast by Region (2025-2032) & (M USD)
Table 176. North America Contraceptives Drugs and Devices Sales Forecast by Country (2025-2032) & (K Units)
Table 177. North America Contraceptives Drugs and Devices Market Size Forecast by Country (2025-2032) & (M USD)
Table 178. Europe Contraceptives Drugs and Devices Sales Forecast by Country (2025-2032) & (K Units)
Table 179. Europe Contraceptives Drugs and Devices Market Size Forecast by Country (2025-2032) & (M USD)
Table 180. Asia Pacific Contraceptives Drugs and Devices Sales Forecast by Region (2025-2032) & (K Units)
Table 181. Asia Pacific Contraceptives Drugs and Devices Market Size Forecast by Region (2025-2032) & (M USD)
Table 182. South America Contraceptives Drugs and Devices Sales Forecast by Country (2025-2032) & (K Units)
Table 183. South America Contraceptives Drugs and Devices Market Size Forecast by Country (2025-2032) & (M USD)
Table 184. Middle East and Africa Contraceptives Drugs and Devices Consumption Forecast by Country (2025-2032) & (Units)
Table 185. Middle East and Africa Contraceptives Drugs and Devices Market Size Forecast by Country (2025-2032) & (M USD)
Table 186. Global Contraceptives Drugs and Devices Sales Forecast by Type (2025-2032) & (K Units)
Table 187. Global Contraceptives Drugs and Devices Market Size Forecast by Type (2025-2032) & (M USD)
Table 188. Global Contraceptives Drugs and Devices Price Forecast by Type (2025-2032) & (USD/Unit)
Table 189. Global Contraceptives Drugs and Devices Sales (K Units) Forecast by Application (2025-2032)
Table 190. Global Contraceptives Drugs and Devices Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Contraceptives Drugs and Devices
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Contraceptives Drugs and Devices Market Size (M USD), 2019-2032
Figure 5. Global Contraceptives Drugs and Devices Market Size (M USD) (2019-2032)
Figure 6. Global Contraceptives Drugs and Devices Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Contraceptives Drugs and Devices Market Size by Country (M USD)
Figure 11. Contraceptives Drugs and Devices Sales Share by Manufacturers in 2023
Figure 12. Global Contraceptives Drugs and Devices Revenue Share by Manufacturers in 2023
Figure 13. Contraceptives Drugs and Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Contraceptives Drugs and Devices Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Contraceptives Drugs and Devices Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Contraceptives Drugs and Devices Market Share by Type
Figure 18. Sales Market Share of Contraceptives Drugs and Devices by Type (2019-2024)
Figure 19. Sales Market Share of Contraceptives Drugs and Devices by Type in 2023
Figure 20. Market Size Share of Contraceptives Drugs and Devices by Type (2019-2024)
Figure 21. Market Size Market Share of Contraceptives Drugs and Devices by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Contraceptives Drugs and Devices Market Share by Application
Figure 24. Global Contraceptives Drugs and Devices Sales Market Share by Application (2019-2024)
Figure 25. Global Contraceptives Drugs and Devices Sales Market Share by Application in 2023
Figure 26. Global Contraceptives Drugs and Devices Market Share by Application (2019-2024)
Figure 27. Global Contraceptives Drugs and Devices Market Share by Application in 2023
Figure 28. Global Contraceptives Drugs and Devices Sales Growth Rate by Application (2019-2024)
Figure 29. Global Contraceptives Drugs and Devices Sales Market Share by Region (2019-2024)
Figure 30. North America Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Contraceptives Drugs and Devices Sales Market Share by Country in 2023
Figure 32. U.S. Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Contraceptives Drugs and Devices Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Contraceptives Drugs and Devices Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Contraceptives Drugs and Devices Sales Market Share by Country in 2023
Figure 37. Germany Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Contraceptives Drugs and Devices Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Contraceptives Drugs and Devices Sales Market Share by Region in 2023
Figure 44. China Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Contraceptives Drugs and Devices Sales and Growth Rate (K Units)
Figure 50. South America Contraceptives Drugs and Devices Sales Market Share by Country in 2023
Figure 51. Brazil Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Contraceptives Drugs and Devices Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Contraceptives Drugs and Devices Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Contraceptives Drugs and Devices Production Market Share by Region (2019-2024)
Figure 62. North America Contraceptives Drugs and Devices Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe Contraceptives Drugs and Devices Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan Contraceptives Drugs and Devices Production (K Units) Growth Rate (2019-2024)
Figure 65. China Contraceptives Drugs and Devices Production (K Units) Growth Rate (2019-2024)
Figure 66. Global Contraceptives Drugs and Devices Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Contraceptives Drugs and Devices Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Contraceptives Drugs and Devices Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Contraceptives Drugs and Devices Market Share Forecast by Type (2025-2032)
Figure 70. Global Contraceptives Drugs and Devices Sales Forecast by Application (2025-2032)
Figure 71. Global Contraceptives Drugs and Devices Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Contraceptives Drugs and Devices
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Contraceptives Drugs and Devices Market Size (M USD), 2019-2032
Figure 5. Global Contraceptives Drugs and Devices Market Size (M USD) (2019-2032)
Figure 6. Global Contraceptives Drugs and Devices Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Contraceptives Drugs and Devices Market Size by Country (M USD)
Figure 11. Contraceptives Drugs and Devices Sales Share by Manufacturers in 2023
Figure 12. Global Contraceptives Drugs and Devices Revenue Share by Manufacturers in 2023
Figure 13. Contraceptives Drugs and Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Contraceptives Drugs and Devices Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Contraceptives Drugs and Devices Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Contraceptives Drugs and Devices Market Share by Type
Figure 18. Sales Market Share of Contraceptives Drugs and Devices by Type (2019-2024)
Figure 19. Sales Market Share of Contraceptives Drugs and Devices by Type in 2023
Figure 20. Market Size Share of Contraceptives Drugs and Devices by Type (2019-2024)
Figure 21. Market Size Market Share of Contraceptives Drugs and Devices by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Contraceptives Drugs and Devices Market Share by Application
Figure 24. Global Contraceptives Drugs and Devices Sales Market Share by Application (2019-2024)
Figure 25. Global Contraceptives Drugs and Devices Sales Market Share by Application in 2023
Figure 26. Global Contraceptives Drugs and Devices Market Share by Application (2019-2024)
Figure 27. Global Contraceptives Drugs and Devices Market Share by Application in 2023
Figure 28. Global Contraceptives Drugs and Devices Sales Growth Rate by Application (2019-2024)
Figure 29. Global Contraceptives Drugs and Devices Sales Market Share by Region (2019-2024)
Figure 30. North America Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Contraceptives Drugs and Devices Sales Market Share by Country in 2023
Figure 32. U.S. Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Contraceptives Drugs and Devices Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Contraceptives Drugs and Devices Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Contraceptives Drugs and Devices Sales Market Share by Country in 2023
Figure 37. Germany Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Contraceptives Drugs and Devices Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Contraceptives Drugs and Devices Sales Market Share by Region in 2023
Figure 44. China Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Contraceptives Drugs and Devices Sales and Growth Rate (K Units)
Figure 50. South America Contraceptives Drugs and Devices Sales Market Share by Country in 2023
Figure 51. Brazil Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Contraceptives Drugs and Devices Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Contraceptives Drugs and Devices Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Contraceptives Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Contraceptives Drugs and Devices Production Market Share by Region (2019-2024)
Figure 62. North America Contraceptives Drugs and Devices Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe Contraceptives Drugs and Devices Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan Contraceptives Drugs and Devices Production (K Units) Growth Rate (2019-2024)
Figure 65. China Contraceptives Drugs and Devices Production (K Units) Growth Rate (2019-2024)
Figure 66. Global Contraceptives Drugs and Devices Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Contraceptives Drugs and Devices Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Contraceptives Drugs and Devices Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Contraceptives Drugs and Devices Market Share Forecast by Type (2025-2032)
Figure 70. Global Contraceptives Drugs and Devices Sales Forecast by Application (2025-2032)
Figure 71. Global Contraceptives Drugs and Devices Market Share Forecast by Application (2025-2032)
